Expanding Sales of Existing AI Products and Developing New Services
First written in FY2022-Q3. 16 of 18 entries say "Advanced", first in FY2022. Latest entry: 2026-08-12.
24 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「“exaBase DX Assessment & Learning,” which develops DX talent for companies and local governments, continued to grow, reaching 2,534 adopting companies and approximately 420,000 users as of March 2026. “exaBase Generative AI” performed strongly, with 1,422 adopting companies and approximately 120,000 users as of March 2026.」
The number of companies and users adopting existing products and generative AI services expanded, reaching specific levels as of March 2026. - FY2026-H1AdvancedAnnual report
「“exaBase DX Assessment & Learning” performed strongly, with 2,452 adopting companies and approximately 360,000 users as of September 2025. “exaBase Generative AI” also performed strongly, with 1,068 adopting companies and approximately 110,000 users as of September 2025.」
The number of companies and users adopting existing products and generative AI services expanded, reaching specific levels as of September 2025. - FY2025AdvancedAnnual report
「The number of companies adopting “exaBase DX Assessment & Learning” reached 2,047 as of March 2025, with 306,655 users, and continued to increase. “exaBase Generative AI” performed strongly, with the number of adopting companies exceeding 827 as of March 2025, with 83,047 users.」
The scale of adoption of existing products and generative AI services expanded, measured by the number of adopting companies and users. - FY2024-Q3AdvancedAnnual report
「The number of companies adopting “exaBase DX Assessment & Learning,” which identifies and develops corporate DX talent, reached 1,391 as of December 2023, with 178,011 users, and continued to increase. “exaBase Generative AI powered by GPT-４” was adopted by 315 companies as of December 2023, with 35,800 users, and performed strongly, with the number of users exceeding 40,000 in January 2024.」
In addition to expanding sales of existing products, the note shows specific progress in adoption scale, including 315 companies and 35,800 people adopting the generative AI service and more than 40,000 users. - FY2024-Q2AdvancedAnnual report
「During the cumulative second quarter, in addition to expanding sales of existing products, we worked on developing new services, including the use of generative AI, based on knowledge gained through the AI platform business.」
In addition to expanding sales of existing products, the company is developing new services using generative AI and other technologies. - FY2024-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 14 August 2023, our company resolved that, with 2 October 2023 as the scheduled effective date, the rights and obligations relating to its generative AI product business would be transferred through an incorporation-type company split to the newly established company Exa Enterprise AI, a wholly owned subsidiary of our company.」
In addition to expanding sales of existing products and developing new services, the company resolved specific organizational measures to transfer the generative AI product business to a wholly owned subsidiary. - FY2023AdvancedAnnual report
「In the social AI product suite, sales expansion progressed for CareWiz トルト through collaboration with a partner company.」
The note describes sales expansion for the existing product CareWiz トルト through collaboration with a partner company and clarifies the focus areas following the transfer of CareWiz ハナスト. - FY2023-Q3ReframedAnnual report
「We will accelerate the development and rollout of the existing AI product CareWiz トルト, while focusing on developing AI products and rolling out services in new fields that help address challenges related to the management of nursing care providers.」
Following the transfer of CareWiz ハナスト, the company has indicated that it will accelerate the development and rollout of existing AI products, centered on CareWiz トルト, and focus on new areas in the nursing care sector. - FY2023-Q2AdvancedAnnual report
「The number of companies adopting the DX AI product suite increased, led by “exaBase DX Assessment & Learning” for identifying and developing corporate DX talent. In the social AI product suite, sales expansion progressed for “CareWiz トルト” and “CareWiz ハナスト” through collaboration with their respective partner companies.」
In addition to the increase in companies adopting existing products, sales expansion progressed for CareWiz トルト and CareWiz ハナスト through collaboration with partner companies. - FY2022AdvancedAnnual report
「The number of companies adopting the DX AI product suite increased, led by “exaBase DX Assessment & Learning” for identifying and developing corporate DX talent and “exaBase Forecasting & Analytics” for data utilization and analysis.」
The note describes an increase in the number of companies adopting existing products and progress in developing new services based on knowledge gained from the platform business. - FY2022-Q3First statedAnnual report
「During the current third-quarter consolidated cumulative period, in addition to expanding sales of existing products, we worked on developing new services based on the expertise gained through the AI Platform Business.」
The company is applying expertise gained in the platform business to the product business, pursuing expanded sales of existing products and the development of new services in parallel.